Sounds very encouraging
A phase 2 study of ruxolitinib in combination wi... - MPN Voice
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis
Written by
Paul123456
To view profiles and participate in discussions please or .
Read more about...
4 Replies
•
Thanks for sharing. The arguments of synergies in medicine continue to be a good and " low cost" form of clinical trial. Every bit helps I guess...
Thanks for posting this -sounds positive.
I try hard to understand, IF a treatment that will have a positive outcome on bone marrow fibrosis, will prolong life expectancy or halt the disease progression.. But i can't understand what long-term outcome will have.
This synergetic effects could halt the progression of MF?